We're two weeks into NASCAR on Prime Video, with three weeks left on a five-race package that's part of a new seven-year TV ...

The battery tech startup had plans to manufacture its solid-state battery, but it seems to have concluded that there was no ...

Earlier this year, something wild happened at The Dirt Track in Las Vegas. The post Kyle Larson’s 19-Year-Old Replacement ...

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...

The A380 was meant to be more than one aircraft. Airbus proposed multiple spin-offs—including stretched, shortened, and cargo ...

The French pharmaceutical giant is acquiring a Cambridge biotech and its rare immunology disease which is already approved in the U.S. and European Union. CFO of the Year Join us for our 17th ...

Sanofi SA (NASDAQ:SNY) on Monday agreed to acquire Blueprint Medicines Corporation (NASDAQ:BPMC). The acquisition includes a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib ...

One type of room is what the game calls Standard Blueprint Rooms, they’re indicated by a blue border around their edges when they pop up. Now, these are the common rooms that you’ll most ...

Sanofi agreed to buy Blueprint Medicines for up to $9.5 billion, the French drugmaker's biggest move yet to replenish its drug pipeline since it sold a controlling stake in its consumer-healthcare ...

Sanofi SAN-4.84%decrease; red down pointing triangle agreed to buy Blueprint Medicines BPMC-1.66%decrease; red down pointing triangle, a U.S. pharmaceutical company that specializes in rare ...

Sanofi to Buy US Biopharma Group Blueprint for up to $9.5 Billion By Dominique Patton and Geert De Clercq PARIS (Reuters) -France's Sanofi has agreed to buy U.S.-based Blueprint Medicines ...